Interested companies are invited to contact the Consortium. Note that signature of a Non-Disclosure Agreement (NDA) will be requested for additional information. After contacting the Consortium, companies will have to decide on one of the following options to cooperate with the Consortium.
The LoA prices for access to all the registration dossiers for the substances mentioned, including the chemical safety report have been determined as follows:
It is important to note that additional costs will have to be paid to the owners of ther specific studies which were used for the dossier, but who are not members of the Consortium (so-called data owners who are not planning to register synthetic zeolites under REACH). The Consortium has negotiated a fixed price with these companies for access to such studies which will need to be paid directly to such companies.
In case you decide to follow this approach, you will, upon paument of the LoA price, receive a Letter of Access for the registration dossiers, the chemical safety report, and other relevant pieces of information.
This can be useful if you are planning to register another substance with a read accross to your substance from one of the substances covered by the Consortium. Under such circumstances it might be sufficient to purchase a LoA for one or more individual studies owned by members of the Consortium. In this case the costs for a LoA are calculated at a rate of 20% of the reimbursable value of the particular study.
Synthetic Zeolites Consortium aisbl
Reg N°: BE0832.383.823
4 rue des Héritages
5336 Courrière - Belgium
Synthetic Zeolites Consortium aisbl is a non-profit association registered under Belgian laws and representing the members of the Industry Consortium for the REACH Registration of Synthetic Zeolites, namely Synthetic Zeolites Consortium
NB: In any case, it should be noted that the use of the dossier or LoA purchased as described and all information therein contained is strictly confined to REACH registration purposes only of the described substances. Thus, these studies and data may not be used for any other purpose, including, but not limited to, the registration of substances in jurisdictions outside the EU.